Reyrieux, France

Valérie Ravaux

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Valérie Ravaux: Innovator in Pharmaceutical Chemistry

Introduction

Valérie Ravaux is a notable inventor based in Reyrieux, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel crystalline forms of compounds used in antibacterial treatments. With a total of 4 patents to his name, Ravaux's work has the potential to impact the medical field significantly.

Latest Patents

Ravaux's latest patents focus on the crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt, commonly referred to as NXL-104. These inventions describe novel crystalline forms of this sodium salt and compositions that include it, either alone or in combination with antibacterial agents such as ceftaroline fosamil. The patents also detail processes for preparing these crystalline forms and methods for treating bacterial infections using them.

Career Highlights

Throughout his career, Valérie Ravaux has worked with various organizations, including Forest Laboratories Holdings Limited. His expertise in pharmaceutical chemistry has allowed him to contribute to the development of innovative solutions in the treatment of bacterial infections.

Collaborations

Ravaux has collaborated with notable professionals in his field, including Mahendra G Dedhiya and Sisir Bhattacharya. These collaborations have further enriched his research and development efforts.

Conclusion

Valérie Ravaux stands out as an influential inventor in the pharmaceutical industry, with a focus on innovative antibacterial treatments. His contributions through his patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…